- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05494749
Zirconia Reinforced Glass Ionomer in MIH
March 17, 2024 updated by: Hams Hamed Abdelrahman
Effectiveness Of Zirconia Reinforced Glass Ionomer Used In Alternative Restorative Treatment In Molar Incisor Hypomineralization (A Randomized Controlled Clinical Trial And Finite Element Analysis)
Molar-incisor hypomineralization (MIH) is a qualitative enamel defect, in which molars and incisors involved are prone to post-eruptive enamel breakdown leading to sensitivity, and caries.
Atraumatic/Alternative Restorative Treatment (ART) is a minimally invasive procedure.
It can be very beneficial in managing MIH-affected molars in communities with limited access to dental care.
Zirconia-reinforced GI was recently introduced.
It is claimed to serve as a long-term temporary restoration until a more permanent restoration is placed
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
88
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Alexandria, Egypt
- Alexandria Faculty of Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 10 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Children free from any systemic disease (ASA I).
- Cooperative children showing positive or definitely positive behavior according to Frankl rating scale
- Hypomineralized first permanent molars that are restorable according to MIH Treatment Need Index (MIH-TNI): Index (2a), (2b), (4a), (4b)
- Teeth with dentinal lesions corresponding to ICDAS II score 5 or 6
- No clinical or radiographic evidence of pulpal involvement.
Exclusion Criteria:
- Index (0), (1), (2c), (3), (4c) on the MIH Treatment Need Index.
- Patients whose parents will not give their consent to participate in the study
- Non-restorable first permanent molars indicated for extraction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control
|
teeth meeting the inclusion criteria are assigned to receive HVGI-Equia Forte® restorations.
|
Experimental: Test group
|
teeth meeting the inclusion criteria are assigned to receive Zirconomer® restorations
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in clinical success rate
Time Frame: at 3 months, 6 months, 9 months, 12 months
|
It will be assessed using Modified ART criteria, restorations receiving a score of: (0) Restoration is present and satisfactory OR (1) Restoration is present, slight defect at the cavity margin of less than 0.5 mm; no repair is needed. will be considered successful, and any other score will be considered a failure. |
at 3 months, 6 months, 9 months, 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in pain
Time Frame: at 1 week, 3 months, 6 months, 9 months, 12 months
|
Pain will be recorded using VAS Using a visual analog scale (VAS), the subjects were instructed how to point to the position of the line between faces to indicate how much painthey might feel.
In this system, the total scores range from 0 to 100 based on measuring the distance in millimeters from the left end bar to the mark made by the child on the 10 cm line anchored by happy to sad faces, with a higher score indicating more severe pain.
|
at 1 week, 3 months, 6 months, 9 months, 12 months
|
Change in sensitivity
Time Frame: at 1 week, 3 months, 6 months, 9 months, 12 months
|
sensitivity will be recorded using VAS by performing air blast test Using a visual analog scale (VAS), the subjects were instructed how to point to the position of the line between faces to indicate how much pain they might feel.
In this system, the total scores range from 0 to 100 based on measuring the distance in millimeters from the left end bar to the mark made by the child on the 10 cm line anchored by happy to sad faces, with a higher score indicating more severe pain.
|
at 1 week, 3 months, 6 months, 9 months, 12 months
|
Finite element analysis
Time Frame: 12 months
|
Performance of both Zirconomer and HVGI-Equia Forte under dynamic occlusal loads will be assessed using Finite Element Analysis using ANSYS software.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Reham A Mahfouz, MSc, Alexandria University, Faculty of dentistry
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2022
Primary Completion (Actual)
December 30, 2023
Study Completion (Actual)
December 30, 2023
Study Registration Dates
First Submitted
August 8, 2022
First Submitted That Met QC Criteria
August 8, 2022
First Posted (Actual)
August 10, 2022
Study Record Updates
Last Update Posted (Actual)
March 19, 2024
Last Update Submitted That Met QC Criteria
March 17, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MIH_2022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Molar Incisor Hypomineralization
-
Cairo UniversityCompletedHypomineralization of Enamel | Hypomineralization Molar IncisorEgypt
-
University of Nove de JulhoRecruiting
-
Marmara UniversityNot yet recruitingMolar-Incisor Hypomineralization
-
Marmara UniversityNot yet recruitingMolar-Incisor Hypomineralization
-
University of Nove de JulhoNot yet recruitingHypomineralization Molar Incisor
-
Marmara UniversityNot yet recruitingMolar-Incisor Hypomineralisation
-
Universidade CeumaFundação de Amparo à Pesquisa e Desenvolvimento Científico do MaranhãoCompletedHypomineralization Molar IncisorBrazil
-
University of PaviaNot yet recruitingMolar Incisor HypomineralizationItaly
-
Mansoura UniversityCompletedMolar Incisor HypomineralizationEgypt
-
Universidad Nacional Autonoma de MexicoRecruitingMolar Incisor HypomineralizationMexico
Clinical Trials on zirconomer
-
Al-Azhar UniversityCompleted
-
Cairo UniversityCompletedPerformance | GeriatricEgypt
-
Cairo UniversityNot yet recruitingDental Caries in Children | Dental Materials